Abstract
Diphtheria toxin remains one of the most successfully studied of the bacterial protein toxins. A detailed understanding of the structure function relationships of the toxin and the role of each domain in the intoxication process is well understood. This understanding has led to the development of diphtheria toxin-related fusion protein toxins which are targeted toward specific cell surface receptors. The first of these targeted toxins are now approved for human clinical use in the treatment of refractory hematologic malignancies and graft-versus-host disease. In recent years, studies on the molecular mechanism by which the diphtheria toxin catalytic domain is translocated across the early endosomal membrane has revealed that a host cell cytosolic translocation factor complex facilitates the entry process. A detailed understanding of this process will further stimulate the development of new approaches toward the delivery of cargo, ranging from protein to nucleic acid and/or protein nucleic acids, to the eukaryotic cell cytosol.
Preview
Unable to display preview. Download preview PDF.
References
1. Aniento F, Gu F, Parton RG, Gruenberg J (1996) An endosomal beta COP is involved in the pH-dependent formation of transport vesicles destined for late endosomes. J Cell Biol 133:29-41
2. Ariansen S, Afanasiev BN, Moskaug JO, Stenmark H, Madshus IH, Olsnes S (1993) Membrane translocation of diphtheria toxin A-fragment: role of carboxy-terminal region. Biochemistry 32:83-90
3. Bacha P, Williams DP, Waters C, Williams JM, Murphy JR, Strom TB (1988) Interleukin 2 receptor-targeted cytotoxicity. Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein. J Exp Med 167:612-622
4. Bennett MJ, Choe S, Eisenberg D (1994) Domain swapping: entangling alliances between proteins. Proc Natl Acad Sci USA 91:3127-3131
5. Blewitt MG, Chung LA, London E (1985) Effect of pH on the conformation of diphtheria toxin and its implications for membrane penetration. Biochemistry 24:5458-5464
6. Bomsel M, Parton R, Kuznetsov SA, Schroer TA, Gruenberg J (1990) Microtubule- and motor-dependent fusion in vitro between apical and basolateral endocytic vesicles from MDCK cells. Cell 62:719-731
7. Boquet P, Pappenheimer AM Jr (1976) Interaction of diphtheria toxin with mammalian cell membranes. J Biol Chem 251:5770-5778
8. Bosshart H, Humphrey J, Deignan E, Davidson J, Drazba J, Yuan L, Oorschot V, Peters PJ, Bonifacino JS (1994) The cytoplasmic domain mediates localization of furin to the trans-Golgi network en route to the endosomal/lysosomal system. J Cell Biol 126:1157-1172
9. Bowman EJ, Siebers A, Altendorf K (1988) Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci USA 85:7972-7976
10. Brandl CJ, Deber CM (1986) Hypothesis about the function of membrane-buried proline residues in transport proteins. Proc Natl Acad Sci USA 83:917-921
11. Cabiaux V, Quertenmont P, Conrath K, Brasseur R, Capiau C, Ruysschaert JM (1994) Topology of diphtheria toxin B fragment inserted in lipid vesicles. Mol Microbiol 11:43-50
12. Carroll SF, Collier RJ (1984) NAD binding site of diphtheria toxin: identification of a residue within the nicotinamide subsite by photochemical modification with NAD. Proc Natl Acad Sci USA 81:3307-3311
13. Chang MP, Mallet WG, Mostov KE, Brodsky FM (1993) Adaptor self-aggregation, adaptor-receptor recognition and binding of alpha-adaptin subunits to the plasma membrane contribute to recruitment of adaptor (AP2) components of clathrin-coated pits. EMBO J 12:2169-2180
14. Clague MJ, Urbe S, Aniento F, Gruenberg J (1994) Vacuolar ATPase activity is required for endosomal carrier vesicle formation. J Biol Chem 269:21-24
15. Choe S, Bennett MJ, Fujii G, Curmi PM, Kantardjieff KA, Collier RJ, Eisenberg D (1992) The crystal structure of diphtheria toxin. Nature 357:216-222
16. Collier RJ, Cole HA (1969) Diphtheria toxin subunit active in vitro. Science 164:1179-1181
17. Collier RJ, Kandel J (1971) Structure and activity of diphtheria toxin. I. Thiol-dependent dissociation of a fraction of toxin into enzymatically active and inactive fragments. J Biol Chem 246:1496-1503
18. Damke H, Gossen M, Freundlieb S, Bujard H, Schmid SL (1995) Tightly regulated and inducible expression of dominant interfering dynamin mutant in stably transformed HeLa cells. Methods Enzymol 257:209-220
19. Deber CM, Glibowicka M, Woolley GA (1990) Conformations of proline residues in membrane environments. Biopolymers 29:149-157
20. Donovan JJ, Simon MI, Draper RK, Montal M (1981) Diphtheria toxin forms transmembrane channels in planar lipid bilayers. Proc Natl Acad Sci USA 78:172-176
21. Dorland RB, Middlebrook JL, Leppla SH (1979) Receptor-mediated internalization of diphtheria toxin by monkey kidney cells. J Biol Chem 254:11337-11342
22. Drazin R, Kandel J, Collier RJ (1971) Structure and activity of diphtheria toxin. II. Attack by trypsin at a specific site within the intact toxin molecule. J Biol Chem 246:1504-1510
23. Falnes PO, Madshus IH, Sandvig K, Olsnes S (1992) Replacement of negative by positive charges in the presumed membrane-inserted part of diphtheria toxin B fragment. Effect on membrane translocation and on formation of cation channels. J Biol Chem 267:12284-12290
24. Falnes PO, Choe S, Madshus IH, Wilson BA, Olsnes S (1994) Inhibition of membrane translocation of diphtheria toxin A-fragment by internal disulfide bridges. J Biol Chem 269:8402-8407
25. Fingerhut A, von Figura K, Honing S (2001) Binding of AP2 to sorting signals is modulated by AP2 phosphorylation. J Biol Chem 276:5476-5482
26. Freedman RB, Bulleid NJ, Hawkins HC, Paver JL (1989) Role of protein disulphide-isomerase in the expression of native proteins. Biochem Soc Symp 55:167-192
27. Futter CE, Pearse A, Hewlett JL, Hopkins CR (1996) Multivesicular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes. J Cell Biol 132:1011-1023
28. Gill DM, Dinius LL (1971) Observations of the structure of diphtheria toxin. J Biol Chem 246:1492-1495
29. Gill DM, Pappenheimer AM Jr (1971) Structure-activity relationships in diphtheria toxin. J Biol Chem 246:1492-1495
30. Goor RS, Pappenheimer AM Jr (1967) Studies on the mode of action of diphtheria toxin. 3. Site of toxin action in cell-free extracts. J Exp Med 126:899-912
31. Greenfield L, Bjorn MJ, Horn G, Fong D, Buck GA, Collier RJ, Kaplan DA (1983) Nucleotide sequence of the structural gene for diphtheria toxin carried by Corynebacterium diphtheriae. Proc Natl Acad Sci USA 80:6853-6857
32. Gu F, Aniento F, Parton RG, Gruenberg J (1997) Functional dissection of COP-I subunits in the biogenesis of multivesicular endosomes. J Cell Biol 139:1183-1195
33. Hammond K, Caputo GA, London E (2002) Interaction of the membrane-inserted diphtheria toxin T domain with peptides and its possible implications for chaperone-like T domain behavior. Biochemistry 41:3243-3253
34. Hanover JA, Willingham MC, Pastan I (1984) Kinetics of transit of transferrin and epidermal growth factor through clathrin-coated membranes. Cell 39:283-293
35. Ho VT, Zahrieh D, Hochberg E, Micale E, Levin J, Reynolds C, Steckel S, Culter C, Fisher DC, Lee SJ, Alyea EP, Ritz J, Soiffer RJ, Antin JH (2004) Safety and efficacy of denileukin diftitox in patients with steroid refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood 104:1224-1226
36. Hopkins CR, Gibson A, Shipman M, Miller K (1990) Movement of internalized ligand-receptor complexes along a continuous endosomal reticulum. Nature 346:335-339
37. Hu HY, Huynh PD, Murphy JR, vanderSpek JC (1998) The effects of helix breaking mutations in the diphtheria toxin transmembrane domain helix layers of the fusion toxin DAB389IL-2. Protein Eng 11:811-817
38. Iwamoto R, Higashiyama S, Mitamura T, Taniguchi N, Klagsbrun M, Mekada E (1994) Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which upregulates functional receptors and diphtheria toxin sensitivity. EMBO J 13:2322-2330
39. Johnson VG, Nicholls PJ, Habig HW, Youle RJ (1993) The role of proline 345 in diphtheria toxin translocation. J Biol Chem 268:3514-3519
40. Jost M, Simpson F, Kavran JM, Lemmon MA, Schmid SL (1998) Phosphatidylinositol-4,5-bisphosphate is required for endocytic coated vesicle formation. Curr Biol 8:1399-1402
41. Kaczorek M, Delpeyroux F, Chenciner N, Streeck RE, Murphy JR, Boquet P, Tiollais P (1983) Nucleotide sequence and expression of the diphtheria tox228 gene in Escherichia coli. Science 221:855-858
42. Kagan BL, Finkelstein A, Colombini M (1981) Diphtheria toxin fragment forms large pores in phospholipid bilayer membranes. Proc Natl Acad Sci USA 78:4950-4954
43. Keen JH, Maxfield FR, Hardegree MC, Habig WH (1982) Receptor-mediated endocytosis of diphtheria toxin by cells in culture. Proc Natl Acad Sci USA 79:2912-2916
44. Kim K, Groman NB (1965) In vitro inhibition of diphtheria toxin action by ammonium salts and amines. J Bacteriol 90:1552-1556
45. Littleton JT, Barnard RJ, Titus SA, Slind J, Chapman ER, Ganetzky B (2001) SNARE-complex disassembly by NSF follows synaptic-vesicle fusion. Proc Natl Acad Sci USA 98:12233-12238
46. Luzio JP, Mullock BM, Pryor RP, Lindsay MR, James DE, Piper RC (2001) Relationship between endosomes and lysosomes. Biochem Soc Trans 29:476-480
47. Madshus IH (1994a) The N-terminal alpha-helix of fragment B of diphtheria toxin promotes translocation of fragment A into the cytoplasm of eukaryotic cells. J Biol Chem 269:17723-17729
48. Madshus IH, Wiedlocha A, Sandvig K (1994b) Intermediates in translocation of diphtheria toxin across the plasma membrane. J Biol Chem 269:4648-4652
49. Mandel R, Ryser HJ, Ghani F, Wu M, Peak D (1993) Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci USA 90:4112-4116
50. Mayer G, Boileau G, Bendayan M (2004) Sorting of furin in polarized epithelial and endothelial cells: expression beyond the Golgi apparatus. J Histochem Cytochem 52:567-580
51. Merion M, Schlesinger P, Brooks RM, Moehring JM, Moehring TJ, Sly WS (1983) Defective acidification of endosomes in Chinese hamster ovary cell mutants ”cross-resistant” to toxins and viruses. Proc Natl Acad Sci USA 80:5315-5319
52. Middlebrook JL, Dorland RB, Leppla SH (1978) Association of diphtheria toxin with Vero cells. Demonstration of a receptor. J Biol Chem 253:7325-7330
53. Mindell JA, Silverman JA, Collier RJ, Finkelstein A (1992) Locating a residue in the diphtheria toxin channel. Biophys J 62:41-44
54. Mindell JA, Silverman JA, Collier RJ, Finkelstein A (1994a) Structure-function relationships in diphtheria toxin channels: III. Residues which affect the cis pH dependence of channel conductance. J Membr Biol 137:45-57
55. Mindell JA, Zhan H, Huynh PD, Collier RJ, Finkelstein A (1994b) Reaction of diphtheria toxin channels with sulfhydryl-specific reagents: observation of chemical reactions at the single molecule level. Proc Natl Acad Sci USA 91:5272-5276
56. Mitamura T, Iwamoto R, Umata T, Yomo T, Urabe I, Tsuneoka M, Mekada E (1992) The 27-kD diphtheria toxin receptor-associated protein (DRAP27) from vero cells is the monkey homologue of human CD9 antigen: expression of DRAP27 elevates the number of diphtheria toxin receptors on toxin-sensitive cells. J Cell Biol 118:1389-1399
57. Moskaug JO, Sandvig K, Olsnes S (1988) Low pH-induced release of diphtheria toxin A-fragment in Vero cells. Biochemical evidence for transfer to the cytosol. J Biol Chem 263:2518-2525
58. Moskaug JO, Stenmark H, Olsnes S (1991) Insertion of diphtheria toxin B-fragment into the plasma membrane at low pH. Characterization and topology of inserted regions. J Biol Chem 266:2652-2659
59. Moya M, Dautry-Varsat A, Goud B, Louvard D, Boquet P (1985) Inhibition of coated pit formation in Hep2 cells blocks the cytotoxicity of diphtheria toxin but not that of ricin toxin. J Cell Biol 101:548-559
60. Murphy JR, Bishai W, Borowski M, Miyanohara A, Boyd J, Nagle S (1986) Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion protein. Proc Natl Acad Sci USA 83:8258-8262
61. Naglich JG, Metherall JE, Russell DW, Eidels L (1992a) Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 69:1051-1061
62. Naglich JG, Rolf JM, Eidels L (1992b) Expression of functional diphtheria toxin receptors on highly toxin-sensitive mouse cells that specifically bind radioiodinated toxin. Proc Natl Acad Sci USA 89:2170-2174
63. Neupert W, Brunner M (2002) The protein import motor of mitochondria. Nat Rev Mol Cell Biol 3:555-565
64. Oh KJ, Senzel L, Collier RJ, Finkelstein A (1999) Translocation of the catalytic domain of diphtheria toxin across planar phospholipid bilayers by its own T domain. Proc Natl Acad Sci USA 96:8467-8470
65. O’Keefe DO, Cabiaux V, Choe S, Eisenberg D, Collier RJ (1992) pH-dependent insertion of proteins into membranes: B-chain mutation of diphtheria toxin that inhibits membrane translocation, Glu-349—-Lys. Proc Natl Acad Sci USA 89:6202-6206
66. Pappenheimer AM Jr, Uchida T, Harper AA (1972) An immunological study of the diphtheria toxin molecule. Immunochemistry 9:891-906
67. Pappenheimer AM Jr (1977) Diphtheria toxin. Annu Rev Biochem 46:69-94
68. Papini E, Schiavo G, Sandona D, Rappuoli R, Montecucco C (1989) Histidine 21 is at the NAD+ binding site of diphtheria toxin. J Biol Chem 264:12385-12388
69. Papini E, Schiavo G, Rappuoli R, Montecucco C (1990) Histidine-21 is involved in diphtheria toxin NAD+ binding. Toxicon 28:631-635
70. Papini E, Santucci A, Schiavo G, Domenighini M, Neri P, Rappuoli R, Montecucco C (1991) Tyrosine 65 is photolabeled by 8-azidoadenine and 8-azidoadenosine at the NAD+ binding site of diphtheria toxin. J Biol Chem 266:2494-2498
71. Papini E, Cabrini G, Montecucco C (1993a) The sensitivity of cystic fibrosis cells to diphtheria toxin. Toxicon 31:359-362
72. Papini E, Rappuoli R, Murgia M, Montecucco C (1993b) Cell penetration of diphtheria toxin. Reduction of the interchain disulfide bridge is the rate-limiting step of translocation in the cytosol. J Biol Chem 268:1567-1574
73. Ratts R, vanderSpek JC (2002) Diphtheria toxin: structure function and its clinical applications. In Chimeric Proteins: Mechanisms of action and therapeutic applications (Lorberboum-Galski H, Luzarovici P, eds) Taylor & Francis, London / New York pp. 14-36
74. Ratts R, Zeng H, Berg EA, Blue C, McComb ME, Costello CE, vanderSpek JC, Murphy JR (2003) The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J Cell Biol 160:1139-1150
75. Rayhel EJ, Fields TJ, Albright W, Diamantstein T, Hughes JP (1988) Interleukin 2 and a lactogen regulate proliferation and protein phosphorylation in Nb2 cells. Biochem J 249:333-338
76. Re GG, Waters C, Poisson L, Willingham MC, Sugamura K, Frankel AE (1996) Interleukin 2 (IL-2) receptor expression and sensitivity to diphtheria fusion toxin DAB389IL-2 in cultured hematopoietic cells. Cancer Res 56:2500-2595
77. Ren J, Sharpe JC, Collier RJ, London E (1999) Membrane translocation of charged residues at the tips of hydrophobic helices in the T domain of diphtheria toxin. Biochemistry 38:976-984
78. Richter D, Lipmann F (1970) Separation of mitochondrial and cytoplasmic peptide chain elongation factors from yeast. Biochemistry 9:5065-5070
79. Rosen A, Lundman P, Carlsson M, Bhavani K, Srinivasa BR, Kjellstrom G, Nilsson K, Holmgren A (1995) A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin. Int Immunol 7:625-633
80. Roux E, Yersin, A (1888) Contribution a l’etude de la diphtheriae. Ann Inst Pasteur 2:629-661
81. Rubartelli A, Sitia R (1991) Interleukin 1 beta and thioredoxin are secreted through a novel pathway of secretion. Biochem Soc Trans 19:255-259
82. Ryser HJ, Mandel R, Ghani F (1991) Cell surface sulfhydryls are required for the cytotoxicity of diphtheria toxin but not of ricin in Chinese hamster ovary cells. J Biol Chem 266:18439-18442
83. Sandvig K, Olsnes S (1980) Diphtheria toxin entry into cells is facilitated by low pH. J Cell Biol 87:828-832
84. Sandvig K, Olsnes S (1981b) Rapid entry of nicked diphtheria toxin into cells at low pH. Characterization of the entry process and effects of low pH on the toxin molecule. J Biol Chem 256:9068-9076
85. Sandvig K, Sundan A, Olsnes S (1985) Effect of potassium depletion of cells on their sensitivity to diphtheria toxin and pseudomonas toxin. J Cell Physiol 124:54-60
86. Sandvig K, Olsnes S (1988) Diphtheria toxin-induced channels in Vero cells selective for monovalent cations. J Biol Chem 263:12352-12359
87. Silverman JA, Mindell JA, Zhan H, Finkelstein A, Collier RJ (1994) Structure-function relationships in diphtheria toxin channels: I. Determining a minimal channel-forming domain. J Membr Biol 137:17-28
88. Simpson LL, Coffield JA, Bakry N (1994) Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins. J Pharmacol Exp Ther 269:256-262
89. Smith WP (1980a) Cotranslational secretion of diphtheria toxin and alkaline phosphatase in vitro: involvement of membrane protein(s). J Bacteriol 141:1142-1147
90. Smith WP, Tai PC, Murphy JR, Davis BD (1980) Precursor in cotranslational secretion of diphtheria toxin. J Bacteriol 141:184-189
91. Stenmark H, McGill S, Olsnes S, Sandvig K (1989) Permeabilization of the plasma membrane by deletion mutants of diphtheria toxin. EMBO J 8:2849-2853
92. Takeshita T, Asao H, Ohtani K, Ishii N, Kumaki S, Tanaka N, Munakata H, Nakamura N, Sugamura K (1992) Cloning of the gamma chain of the human IL-2 receptor. Science 257:379-382
93. Tsai B, Ye Y, Rapoport TA (2002) Retro-translocation of proteins from the endoplasmic reticulum into the cytosol. Nat Rev Mol Cell Biol 3:246-255
94. Tsuneoka M, Nakayama K, Hatsuzawa K, Komada M, Kitamura N, Mekada E (1993) Evidence for involvement of furin in cleavage and activation of diphtheria toxin. J Biol Chem 268:26461-26465
95. Uchida T, Gill DM, Pappenheimer AM Jr, Greany R (1971) Mutation in the structural gene for diphtheria toxin carried by temperate phage b. Nature 233:8-11
96. Umata T, Moriyama Y, Futai M, Mekada E (1990) The cytotoxic action of diphtheria toxin and its degradation in intact Vero cells are inhibited by bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase. J Biol Chem 265:21940-21945
97. vanderSpek JC, Mindell JA, Finkelstein A, Murphy JR (1993) Structure/function analysis of the transmembrane domain of DAB389-interleukin-2, an interleukin-2 receptor-targeted fusion toxin. The amphipathic helical region of the transmembrane domain is essential for the efficient delivery of the catalytic domain to the cytosol of target cells. J Biol Chem 268:12077-12082
98. vanderSpek J, Cassidy D, Genbauffe F, Huynh PD, Murphy JR (1994a) An intact transmembrane helix 9 is essential for the efficient delivery of the diphtheria toxin catalytic domain to the cytosol of target cells. J Biol Chem 269:21455-21459
99. vanderSpek JC, Howland K, Friedman T, Murphy JR (1994b) Maintenance of the hydrophobic face of the diphtheria toxin amphipathic transmembrane helix 1 is essential for the efficient delivery of the catalytic domain to the cytosol of target cells. Protein Eng 7:985-989
100. Waldmann TA (1989) Multichain interleukin2 receptor on malignant cells: A target for diagnosis and therapy. Cell Immunol 99:53-60
101. Wibo M, Poole B (1974) Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1. J Cell Biol 63:430-40
102. Wiedlocha A, Madshus IH, Mach H, Middaugh CR, Olsnes S (1992) Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diphtheria toxin as vector. EMBO J 11:4835-4842
103. Williams DP, Parker K, Bacha P, Bishai W, Borowski M, Genbauffe F, Strom TB, Murphy JR (1987) Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. Protein Eng 1:493-498
104. Williams DP, Snider CE, Strom TB, Murphy JR (1990a) Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells. J Biol Chem 265:11885-11889
105. Williams D P, Wen Z, Watson RS, Boyd J, Strom TB, Murphy JR (1990b) Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194. J Biol Chem 265:20673-20677
106. Woolfson DN, Mortishire-Smith RJ, Williams DH (1991) Conserved positioning of proline residues in membrane-spanning helices of ion-channel proteins. Biochem Biophys Res Commun 175:733-737
107. Xu Z, Mayer A, Muller E, Wickner W (1997) A heterodimer of thioredoxin and I(B)2 cooperates with Sec18p (NSF) to promote yeast vacuole inheritance. J Cell Biol 136:299-306
108. Xu Z, Sato K, Wickner W (1998) LMA1 binds to vacuoles at Sec18p (NSF), transfers upon ATP hydrolysis to a t-SNARE (Vam3p) complex, and is released during fusion. Cell 93:1125-1134
109. Zeng H (1998) Translocation of catalytic domain of a diphtheria toxin fusion protein from purified early endosomes. Doctoral Dissertation, Boston University School of Medicine, Boston, MA
110. Zerial M, Stenmark H (1993) Rab GTPases in vesicular transport. Curr Opin Cell Biol 5:613-620
Author information
Authors and Affiliations
Editor information
Rights and permissions
About this chapter
Cite this chapter
Ratts, R., Murphy, J.R. Diphtheria toxin, diphtheria-related fusion protein toxins, and the molecular mechanism of their action against eukaryotic cells. In: Schmitt, M.J., Schaffrath, R. (eds) Microbial Protein Toxins. Topics in Current Genetics, vol 11. Springer, Berlin, Heidelberg. https://doi.org/10.1007/b102267
Download citation
DOI: https://doi.org/10.1007/b102267
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23562-0
Online ISBN: 978-3-540-31455-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)